CVS Health (NYSE:CVS) Lifted to “B-” at TheStreet

Share on StockTwits

TheStreet upgraded shares of CVS Health (NYSE:CVS) from a c+ rating to a b- rating in a research note issued to investors on Monday, TheStreetRatingsTable reports.

Other research analysts also recently issued research reports about the stock. Standpoint Research upgraded shares of CVS Health from a hold rating to a buy rating in a research report on Wednesday, June 5th. Morgan Stanley restated a buy rating and issued a $74.00 price target on shares of CVS Health in a research report on Sunday, August 11th. Citigroup boosted their price target on shares of CVS Health from $68.00 to $72.00 and gave the stock a buy rating in a research report on Thursday, August 8th. Evercore ISI set a $63.00 price target on shares of CVS Health and gave the stock a buy rating in a research report on Wednesday, August 7th. Finally, Cowen restated an outperform rating and issued a $76.00 price target (up previously from $69.00) on shares of CVS Health in a research report on Tuesday, August 27th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. CVS Health has a consensus rating of Buy and a consensus target price of $75.87.

NYSE:CVS traded up $0.17 during mid-day trading on Monday, hitting $64.16. 1,636,264 shares of the company’s stock were exchanged, compared to its average volume of 10,862,482. The company has a 50 day simple moving average of $59.26 and a 200-day simple moving average of $55.85. The company has a current ratio of 0.95, a quick ratio of 0.64 and a debt-to-equity ratio of 1.39. CVS Health has a fifty-two week low of $51.72 and a fifty-two week high of $82.15. The firm has a market capitalization of $82.82 billion, a P/E ratio of 9.06, a PEG ratio of 1.39 and a beta of 0.85.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, topping the consensus estimate of $1.70 by $0.19. The business had revenue of $63.43 billion for the quarter, compared to the consensus estimate of $62.66 billion. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The firm’s revenue was up 35.2% compared to the same quarter last year. During the same period last year, the company earned $1.69 EPS. As a group, analysts expect that CVS Health will post 6.96 earnings per share for the current year.

Large investors have recently added to or reduced their stakes in the company. Mutual Advisors LLC lifted its position in CVS Health by 0.8% during the 2nd quarter. Mutual Advisors LLC now owns 20,641 shares of the pharmacy operator’s stock worth $1,125,000 after acquiring an additional 172 shares during the period. Capital Investment Advisory Services LLC grew its position in CVS Health by 3.8% during the first quarter. Capital Investment Advisory Services LLC now owns 5,128 shares of the pharmacy operator’s stock worth $277,000 after buying an additional 189 shares in the last quarter. Fiduciary Group LLC grew its position in CVS Health by 3.2% during the second quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock worth $353,000 after buying an additional 200 shares in the last quarter. First Command Financial Services Inc. grew its position in CVS Health by 16.0% during the second quarter. First Command Financial Services Inc. now owns 1,464 shares of the pharmacy operator’s stock worth $80,000 after buying an additional 202 shares in the last quarter. Finally, Hudock Capital Group LLC grew its position in CVS Health by 54.0% during the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 202 shares in the last quarter. Institutional investors own 76.06% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Recommended Story: Equal Weight Rating

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.